Abstract Cervical cancer remains a major public health concern in India, contributing significantly to global morbidity and mortality. Persistent infection with high-risk human papillomavirus (HPV) is the primary etiological factor, making vaccination a critical preventive strategy. Recent developments, including the introduction of the indigenous quadrivalent HPV vaccine Cervavac and its proposed inclusion in the Universal Immunization Programme (UIP) for girls aged 9–14 years, represent a significant milestone. However, challenges such as vaccine hesitancy, logistical barriers, and limited awareness must be addressed. A comprehensive approach integrating vaccination, screening, and public education is essential for achieving the World Health Organization’s cervical cancer elimination targets.
Soni et al. (Thu,) studied this question.